The WATER IV Prostate Cancer: Aquablation Therapy Versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer
- Sponsor:
- PROCEPT BioRobotics
- Sponsor Study ID:
- CSP0005
- CTO #:
- 104201
- NCT Number:
- NCT06651632
- Phase:
- N/A
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Prostate
- Study Objectives:
- To evaluate the safety and efficacy of Aquablation Therapy with the AQUABEAM Robotic System and the HYDROS Robotic System to reduce treatment related harm in men with Grade Group (GG) 1 to 3 localized prostate cancer who are candidates for, or have selected, prostatectomy.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Wallen, Eric, at wallene@musc.edu .
- Study Coordinator, Helpinstill, Sarah, at sah277@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina